| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_937da8a34db452f2c779f1a8f4c0bc58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_760275d067cf91fc455741cd4fe7007c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2795-10043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2795-10031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-26 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6869
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6897
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6869
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-18 |
| filingDate |
2018-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae90bea6f79552d1d589eb6586f259ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40c6f2cf707b7024c45c39aff8744265
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6616b04e1d47c22c144633465b0e38df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f90395a767cbbf90347c97e546c43d1b |
| publicationDate |
2020-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3692160-A1 |
| titleOfInvention |
Phage-based detection method for antimicrobial susceptibility testing and identification of bacterial species |
| abstract |
The invention provides methods for determining bacterial identity and susceptibility or resistance to antibiotic or antimicrobial agents. In one embodiment, the bacteria are cultured in the presence or absence of the antibiotic agent to generate a plurality of primary cultures, which are then cultured in the presence or absence of transformation phages to generate a first secondary culture which comprises transformed bacteria that have been treated with the antibiotic agent and a second secondary culture that includes transformed bacteria that have not been treated with the antibiotic agent. Recombinant phages are specific for bacteria and include a heterologous marker. The susceptibility or resistance of the bacteria to the antibiotic or antimicrobial agent is determined by comparing a level or activity of the marker in the first and second secondary cultures. |
| priorityDate |
2017-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |